论文部分内容阅读
美国芝加哥论坛报称,Vander-bilt大学的研究人员正着手对一种药物进行I期人体试验,他们希望此药最终成为有效的男性避孕药. 初期试验表明,该避孕药即黄体生成素释放激素(LHR H)拮抗剂在给8名男子服用三星期后,未见副作用. 下阶段试验将在今年夏季开始试验涉及12名男
The Chicago Tribune in the United States reported that researchers at Vanderbilt University are conducting a phase I human trial of a drug that they hope will eventually become a potent male contraceptive.Early trials have shown that the contraceptive, the somatropin-releasing hormone (LHR H) antagonists showed no side effects after taking three weeks to eight men.The next phase of the trial will start in summer this summer involving 12 men